What is Bad Blood?
Bad Blood operates within the burgeoning vaping industry, focusing on providing comprehensive reviews and insights into a wide array of vaping products. Their content spans e-liquids, CBD, and THC offerings, catering to both seasoned vaping enthusiasts seeking the latest flavors and trends, and individuals interested in the DIY e-juice scene. The company's mission is to empower consumers with the knowledge needed to make informed purchasing decisions, emphasizing quality and variety in their curated content. This strategic focus aims to guide consumers through the evolving landscape of vaping experiences.
How much funding has Bad Blood raised?
Bad Blood has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2021): $89K with participation from PPP
Key Investors in Bad Blood
PPP
Public-Private Partnership
What's next for Bad Blood?
With significant Series B/C stage funding, Bad Blood is poised for accelerated growth and market expansion. The substantial expansion capital is expected to fuel strategic initiatives, potentially including enhanced content development, broader product category coverage, and increased marketing efforts to reach a wider audience. Further investment in technology and user engagement platforms may also be on the horizon, solidifying Bad Blood's position as a key authority in the vaping product review space. The company's trajectory suggests a continued focus on guiding consumer choices within the dynamic vaping market.
See full Bad Blood company page
